• Cytomedix Inc., of Gaithersburg, Md., said it signed an agreement with the National Institutes of Health to collaborate on a Phase II study in patients with intermittent claudication, which is caused by peripheral arterial disease.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST